The Florey Department of Neuroscience and Mental Health is home to Australia’s largest cohort of researchers investigating more than 20 diseases and disorders of the brain.
The Florey is embedded in the growing Melbourne Biomedical Precinct, building relationships through international negotiations with a variety of government and scientific leaders. Our proximity to two tertiary hospitals – Austin Health and the Royal Melbourne Hospital - allows direct access to patients and clinical expertise.
Florey researchers collaborate across disciplines with 70 per cent devoted to basic science and 30 per cent to translational research. Diseases investigated include epilepsy, stroke, Alzheimer’s disease, Parkinson's disease, multiple sclerosis, Huntington's disease, motor neurone disease, traumatic brain and spinal cord injury as well as threats to mental health including depression, schizophrenia, bipolar disorders and addiction.
World class research platforms available include imaging technology, histology, bioinformatics, statistics and decision-making analysis, a brain bank and clinical trials.
Professor Trevor Kilpatrick is the Interim Head of the Florey Department of Neuroscience and Mental Health, and Director of The Florey Institute of Neuroscience and Mental Health. Research facilities are located at the Florey's three campuses – in Parkville, at Austin Health and at the Royal Melbourne Hospital.
See here for further information on opportunities for students to study at the Florey and research at The Florey Institute of Neuroscience and Mental Health.